You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 18, May 14, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Breast Cancer
 •Radiologic Imaging
 •Women's Health
 •Women's Health, Other
 •Diagnosis
 •Magnetic Resonance Imaging
 •Mammography
 •Ultrasonography
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

The "Coming of Age" of Nonmammographic Screening for Breast Cancer

Christiane K. Kuhl, MD

JAMA. 2008;299(18):2203-2205.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The study by Berg and colleagues1 published in this issue of JAMA addresses important clinical questions: What is the additional cancer diagnosis yield of screening ultrasound in women at increased risk of breast cancer, and what are the "costs" of such strategies in terms of false-positive diagnoses. The design of this American College of Radiology Imaging Network (ACRIN) trial, from the multi-institutional setting to source documentation and independent data analysis, is excellent from every aspect. This study and several other previously published trials2-4 demonstrate how important it is to have institutions like ACRIN sponsor and help organize prospective clinical trials that follow good clinical practice in the world of diagnostic imaging, which, unlike clinical research in the therapeutic sector, has to proceed without the financial support and scientific infrastructure usually provided by the pharmaceutical and medical device industries.

The results of this study are impressive. Ultrasound . . . [Full Text of this Article]

Author Affiliation: Department of Radiology, University of Bonn, Bonn, Germany.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTERS

Nonmammographic Screening for Breast Cancer
John D. Keen
JAMA. 2008;300(13):1515-1516.
EXTRACT | FULL TEXT  

Nonmammographic Screening for Breast Cancer—Reply
Christiane K. Kuhl
JAMA. 2008;300(13):1516-1517.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
Wendie A. Berg, Jeffrey D. Blume, Jean B. Cormack, Ellen B. Mendelson, Daniel Lehrer, Marcela Böhm-Vélez, Etta D. Pisano, Roberta A. Jong, W. Phil Evans, Marilyn J. Morton, Mary C. Mahoney, Linda Hovanessian Larsen, Richard G. Barr, Dione M. Farria, Helga S. Marques, Karan Boparai, and for the ACRIN 6666 Investigators
JAMA. 2008;299(18):2151-2163.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Science Is Needed
Kopans and Hall
Radiology 2008;249:719-720.
FULL TEXT  

Nonmammographic Screening for Breast Cancer
Keen
JAMA 2008;300:1515-1516.
FULL TEXT  

Ultrasound, Mammography, or Both for Breast Cancer Detection?
JWatch Women's Health 2008;2008:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.